HSP-90 Inhibitor Ganetespib is Synergistic with Doxorubicin in Small Cell Lung Cancer

SCLC at advanced stage is considered an incurable disease. Despite good response to initial chemotherapy, the responses in SCLC patients with metastatic disease are of short duration and resistance inevitably occurs. Although several target-specific drugs have altered the paradigm of treatment for m...

Descripción completa

Detalles Bibliográficos
Autores principales: Lai, Chien-Hao, Park, Kang-Seo, Lee, Dae-Hao, Alberobello, Anna Teresa, Raffeld, Mark, Pierobon, Mariaelena, Pin, Elisa, Petricoin, Emanuel F., Wang, Yisong, Giaccone, Giuseppe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2013
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4002667/
https://www.ncbi.nlm.nih.gov/pubmed/24166505
http://dx.doi.org/10.1038/onc.2013.439

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4002667/
https://www.ncbi.nlm.nih.gov/pubmed/24166505
http://dx.doi.org/10.1038/onc.2013.439

Ejemplares similares